Concepedia

Sureshbabu Mangali

SM

Statistics

Publications

8

Citations

209

H-Index

8

Active since

2018

Affiliations

Central University of Jammu(Current)

Birla Institute of Technology and Science - Hyderabad Campus

University of Vienna

University of Bergen

Sureshbabu Mangali is an author at Central University of Jammu specializing in pharmacology, medicine, and cell signaling.

Publications per year

2018–2022

8

Publications

8

Inhibition of protein kinase R protects against palmitic acid–induced inflammation, oxidative stress, and apoptosis through the JNK/NF‐kB/NLRP3 pathway in cultured H9C2 cardiomyocytes

Sureshbabu Mangali, Audesh Bhat, Mary Priyanka Udumula et al. · Journal of Cellular Biochemistry · 2018 · 77 citations

Life Sciences, Biochemistry, Pharmacology +17

Upregulation of PKR pathway mediates glucolipotoxicity induced diabetic cardiomyopathy in vivo in wistar rats and in vitro in cultured cardiomyocytes

Sureshbabu Mangali, Audesh Bhat, Kirtikumar B. Jadhav et al. · Biochemical Pharmacology · 2020 · 26 citations

Life Sciences, Biochemistry, Cardiology +14

High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin-3-hydrazone via downregulation of PKR pathway in Wistar rats

Mary Priyanka Udumula, Sureshbabu Mangali, Jaspreet Kalra et al. · Scientific Reports · 2021 · 25 citations · Full text

Medicine, Endocrinology, Pharmacology +17

PKR inhibitor imoxin prevents hypertension, endothelial dysfunction and cardiac and vascular remodelling in L-NAME-treated rats

Jaspreet Kalra, Deepika Dasari, Audesh Bhat et al. · Life Sciences · 2020 · 22 citations

Medicine, Cardiology, Pharmacology +15

Canagliflozin and Dapagliflozin Attenuate Glucolipotoxicity-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Inhibition of Sodium-Glucose Cotransporter-1

Deepika Dasari, Audesh Bhat, Sureshbabu Mangali et al. · ACS Pharmacology & Translational Science · 2022 · 21 citations · Full text

Medicine, Cardiology, Pharmacology +15

1–5 of 8